Adaptimmune Therapeutics (ADAP:NAS) Fundamental Valuation Report
Fundamental Valuation Report Adaptimmune Therapeutics(ADAP:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$5.04 (USD) 04/14/2021 Weighted Valuation$5.05 (USD) Overall RatingFairly valued to slightly Undervalued by 0.3% Valuation Models Comparables: $7.73 …
Adaptimmune Therapeutics (ADAP:NAS) Fundamental Valuation Report Read more »
Read More